FMR LLC - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 36 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,942,156
+31.1%
6,780,726
+98.2%
0.00%
Q4 2022$2,244,836
-23.5%
3,420,963
+0.2%
0.00%
Q3 2022$2,936,000
+110.8%
3,413,863
+34.5%
0.00%
Q2 2022$1,393,000
-52.0%
2,537,723
-3.0%
0.00%
Q1 2022$2,903,000
-35.5%
2,615,010
-0.1%
0.00%
Q4 2021$4,502,000
-44.6%
2,617,410
-1.2%
0.00%
-100.0%
Q3 2021$8,131,000
-22.1%
2,648,610
-1.0%
0.00%0.0%
Q2 2021$10,432,000
+37.2%
2,674,811
-1.9%
0.00%0.0%
Q1 2021$7,606,000
-8.6%
2,726,311
+0.2%
0.00%0.0%
Q4 2020$8,322,000
-50.0%
2,719,711
-0.6%
0.00%
-50.0%
Q3 2020$16,639,000
+2.6%
2,736,711
-0.3%
0.00%0.0%
Q2 2020$16,218,000
+123.0%
2,744,117
-0.0%
0.00%
+100.0%
Q1 2020$7,272,000
+5.6%
2,744,130
+8.4%
0.00%0.0%
Q4 2019$6,885,000
-79.2%
2,531,478
-7.5%
0.00%
-75.0%
Q3 2019$33,170,000
+5.8%
2,736,788
-0.0%
0.00%0.0%
Q2 2019$31,341,0002,737,2480.00%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Slate Path Capital LP 7,157,601$3,105,6830.15%
Artal Group S.A. 2,779,122$1,2060.07%
MFN Partners Management, LP 3,389,215$1,470,5800.07%
Intrinsic Value Partners, LLC 43,105$18,7030.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,000$49,8990.00%
Penobscot Investment Management Company, Inc. 10,000$4,3390.00%
COLONY GROUP LLC 102,884$440.00%
CAPTRUST FINANCIAL ADVISORS 292,645$126,9790.00%
GEODE CAPITAL MANAGEMENT, LLC 592,237$256,9710.00%
STATE STREET CORP 115,414$50,0780.00%
View complete list of CYCLERION THERAPEUTICS INC shareholders